Irinotecan Hydrochloride
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996
82e95139-6222-f73d-e053-2a91aa0a4810
HUMAN PRESCRIPTION DRUG LABEL
Jan 14, 2021
Areva Pharmaceuticals, Inc.
DUNS: 833189835
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Irinotecan Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Irinotecan Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Irinotecan Hydrochloride
Product Details
FDA regulatory identification and product classification information